Application deadline: 27th December 2021
CALL FOR PROPOSALS - 2021
For the third consecutive year, PReS and PRINTO are happy to announce the annual call for projects in the context of the cooperation between the PReS Working Parties (WP2.0) and PRINTO, with the aim of fostering excellence in Paediatric Rheumatology from research and training to clinical care and clinical trials. In the first two calls (editions of 2019 and 2020) a total of 14 applications were received and the two winning projects are currently on going.
In this 2021 call, one project will be funded for a total of 3 years. PReS will grant a financial contribution to the winner of 10,000€/year (total 30,000€, covering primarily personnel, meetings and networking costs with volunteer participation from centres), and the equivalent in manpower (30,000€) will be provided by PRINTO. PRINTO will take care of the manpower time for technical assistance and all related infrastructure for implementation of international collaborative studies (feasibility, databases, ethics committees’ submission, data collection etc).
The requirements to participate in the call are the following:
- Applying PI and co-PI (one among the PI and co-PI under 40 years of age) must be members of a PReS WP2.0 and hold a valid PReS membership (please contact email@example.com for further information);
- Applying PI and co-PI must be members of PRINTO (please visit https://www.printo.it/contact/apply-membership or contact firstname.lastname@example.org for further information);
- The support requested to PRINTO must be described clearly in the proposal;
- Partners in the proposal must provide a formal commitment letter of support to the PI on their Institution letterhead with clear indication of their role in the project.
- The proposed project should not have already received additional sources of funding from other organizations/entities which cover the same activities of the present application;
- Patients associations must be involved in the definition of the research needs and in the design of the proposal;
The following features will be taken into account in the evaluation:
- Applying PI of the project and his/her Home institution should be based in a European Pediatric Rheumatology Center;
- Multicentric projects should heavily involve Pediatric Rheumatology Centers based in at least 3 different countries worldwide;
For your information, in the online submission process all applicants will be also required to confirm a general capability of their Home Institution of contracting and invoicing (only applicable for collaborative projects foreseeing compensation to participating centres).
The deadline for presentation of the projects is December 27th, 2021.
For submission inquiries, please contact PRINTO coordinating centre, and you can download here the Grant template to be used. Please consider that any proposal not presented through the official Grant template may be excluded from the evaluation.
Further details on how to submit will follow in due course via e-mail directly to all WP members.
The proposals will be then peer-reviewed by a selection committee including the Research PReS counselor (Chair), 1 PReS Council member, 2 PRINTO Council Members and 1 patient representative.
Any publication(s) arising from the projects will be followed after the byline of authors “for the PReS WP2.0 (name of the WP2.0) and PRINTO” as per the International Committee of Medical Journal Editors (ICMJEs) criteria (http://icmje.org/) and the PRINTO publication policy (https://www.printo.it/publications/authorship-policy). PI and co-PI will be first or last authors.
Nicola Ruperto and Alberto Martini on behalf of PRINTO
Fabrizio De Benedetti, Sylvia Kamphuis, PReS Research Committee
Angelo Ravelli, Michael Beresford, Jelena Vojinovic, PReS Executive
For the 2020 PReS/PRINTO call, the Evaluating Committee has received 6 proposals, all of good quality. We thank all the proponents for their interest and participation.
A call for grant was published in 2019 and resulted in 8 applications and one grant awarded to the project: “Cross-cultural adaptation and validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in juvenile localised scleroderma (JLS): a multicentre study of the PRES scleroderma working party in collaboration with members of the CARRA scleroderma working group” presented by Dr Clare Pain